However, statistically significant correlations were not observed between the serum levels of IL-36β and the serum levels of IL-17 or TNF-α in GBS patients (r = 0.064, P = .688, Fig. 4b; r = 0.093, P = .558, Fig. 4f, respectively). This evidence concerns the gene IL17A and Guillain-Barre syndrome.